Title : 89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

Pub. Date : 2022 May 5

PMID : 35512998






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Background: In the PINCH study we performed 89Zr-DFO-durvalumab (anti-PD-L1) PET/CT in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) prior to monotherapy durvalumab treatment. Deferoxamine CD274 molecule Homo sapiens
2 Secondary aims were to correlate 89Zr-DFO-durvalumab uptake to tumor PD-L1 expression, 18F-FDG uptake, and treatment response of individual lesions. Deferoxamine CD274 molecule Homo sapiens